Tarmo P. Roosild, Ph.D. ([email protected])
Dr. Roosild earned his B.A. in Biochemistry and Cellular Biology with summa cum laude honors from the University of California, San Diego. Following graduation, he completed a five-year tour of duty as a lieutenant in the United States Navy's Nuclear Submarine Force, including certification by the Department of Energy as a Nuclear Engineer. Dr. Roosild returned to UCSD to earn his Ph.D. in Structural Biochemistry. His postdoctoral fellowship was conducted at the Salk Institute for Biological Studies where he was a member of their National Cancer Institute-designated Cancer Center. His research there culminated in the discovery of a novel protein called Mistic, which has been acknowledged by Chemical & Engineering News, the journal of the American Chemical Society, as one of the top four breakthroughs in the field of biochemistry in 2005 (read "Chemistry Highlights 2005"). Dr. Roosild joined the Nevada Cancer Institute's Department of Drug Development in 2006. There he formed the first high resolution structure-determination laboratory in the state of Nevada. His research led to the elucidation of eight unique protein structures, including the first ever structures of two human proteins involved in the metabolism and activation of fluor-uracil-based chemotherapeutics.